Effects of sulphur-containing compounds and X-rays on the mouse erythropoietic system assayed by in-vivo peripheral blood micronucleus test

Strahlentherapie und Onkologie

Volumn 172, Issue 1, 1996, Pages 25-29

  Mazur, L ^a  

^a JAGIELLONIAN UNIVERSITY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

AMIFOSTINE; AMINOETHYLISOTHIOURONIUM; MERCAPTAMINE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; HEMATOPOIESIS; MICRONUCLEUS TEST; MOUSE; RADIATION PROTECTION;

AMIFOSTINE; ANALYSIS OF VARIANCE; ANIMALS; BETA-AMINOETHYL ISOTHIOUREA; CYSTEAMINE; ERYTHROCYTES; ERYTHROPOIESIS; MALE; MICE; MICRONUCLEUS TESTS; RADIATION-PROTECTIVE AGENTS; SULFUR; WHOLE-BODY IRRADIATION;

EID: 0030026443     PISSN: 01797158     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. 2 following treatment with radioprotective drugs Radiat. Res. 122 (1990). 262-267
2. Allalunis-Turner, M. J , T. L. Walden, C. Sawich. Induction of marrow hypoxia by radioprotective agents. Radiat. Res. 118 (1989), 582-586.
3. Almassy, Z , A. B. Krepinsky, A. Biano, G. J Koteles: The present state and perspectives of micronucleus assay in radiation protection. A review. Appl. Radiat. Isot. 4 (1987), 241-249.
4. Bacq, Z. M , G. Dechamps. P Fisher, A. Herve, H. Lebihan, J. Lecomte, M. Pirotte, P. Rayet: Protection against X-rays and therapy of radiation sickness with β-mercaptoethylamine. Science 117 (1953). 633-636
5. Bacq, Z. M., R Goutier: Mechanisms of action of sulfur-containing radioprotectors In. Recovery and repair mechanisms in radiobiology Brook-haven Symp Biol. 20 (1967), 241-262
6. Brooks, A. L., M. A. Khan, R. F. Jostes, F T. Cross: Metaphase chromosome aberrations as markers of radiation exposure and dose. J. Toxicol environ Hlth 40 (1993), 277-288.
7. Brown, P. E., Mechanism of action of aminothiol radioprotectors. Nature 214 (1967), 363-364
8. Chaubey, R. C, H. N. Bhilwade, B. N. Joshi, P. S. Chauhan: Studies on the migration of micronucleated erythrocytes from bone marrow to the peripheral blood in irradiated Swiss mice. Int. J. Radiat Biol 63 (1993), 239-245.
9. Doherty, D. G., W. T. Burnett: Protective effea of S,2-amino-ethylisothiouromum Br.HBr and related compounds against X-radiation death in mice, Proc. Soc. exp. Biol. Med. 89 (1955), 312-314.
10. Fahey, R. C.: Protection of DNA by thiols Pharmac. Ther. 39 (1988), 101-108.
11. Floersheim, G. L., P Floersheim: Protection against ionising radiation and synergism with thiols by zinc aspartate. Brit J. Radiol. 59 (1986), 597-602.
12. Foye, W. O.: Mechanisms of radiation protection by the aminothiols Int. S. Sulfur. Chem. 8 (1973), 161-171.
13. Ghose, A., M. N. Srinivasan: Ineffectiveness of 2-mercaptopropionylglycine in increasing survival of mice after gamma irradiation either alone or in combination with 2-aminoethyl isothiouronium bromide hydrobromide. J. Radiat. Res 21 (1980), 197-203.
14. Grawe, J., G. Zetterberg, H. Amneus: Flow-cytometric enumeration of micronucleated polychromatic erythrocytes in mouse peripheral blood Cytometry 13 (1992), 750-758.
15. Grawe, J., G Zetterberg, H. Amneus. DNA content determination of micronucleated polychromatic erythrocytes induced by clastogens and spindle poisons in mouse bone marrow and peripheral blood. Mutagenesis 8 (1993), 249-255
16. Greenstock, C. L.: Radiation-induced aging and induction and promotion of biological damage. In: Free radicals, aging, and regenerative diseases. Alan R. Liss, Inc., New York 1986, 197-219.
17. Greenstock, C. L : Radiation chemical consideration for the radioprotection of cellular targets. Pharmac. Ther. 39 (1988), 139-145.
18. Hasegawa, A. T., H. D. Landhal: Dose reduction factor for radiation lethality in mice as a function of the dose of mercaptoethylamine. Radiat. Res. 44 (1970), 738-747.
19. Hayashi, M., R. R. Tice, J. T. MacGregor, D. Anderson, D. H. Blakey, M. Kirsch-Volders, F. B. Oleson, F. Pacchierotti, F. Romagna, II. Shimada, S, Sutou, B. Vannier: In vivo rodent erythrocyte micronucleus assay. Mutation Res. 312 (1994), 293-304.
20. Heddle, J. A., J. W Harris: Rapid screening of radioprotective drugs in vivo. Radiat. Res 61 (1975), 50-353.
21. Held, K. D., Model for thiol protection of DNA in cells. Pharmac. Ther. 39 (1988), 123-131.
22. Landauer, M. R., H. D. Davis, J. A. Dominitz, J. F Weiss: Dose and time relationships of the radioprotector WR-2721 on locomotor activity in mice. Pharmacol. Biochem. Behav. 27 (1987), 573-576.
23. Livesey, J. C., Z. Grumbaum, K A. Krohn: Binding of amino-alkylphosphorothioate radioprotective drugs to rodent tissue proteins. Biochem. Pharmacol. 39 (1990), 1807-1812.
24. Maisin, J. R., Protective action, toxicity and mechanisms of action of sulphydryl radioprotectors Studia Biophys. 53 (1975), 121-124.
25. Maity, A., W. G. McKenna, R. J. Muschel: The molecular basis for cell cycle delays following ionizing radiation, a review. Radiother. Oncol. 31 (1994), 1-13.
26. Mavournin, K. H., D. H. Blakey, M. C Cimino, M F. Salamone, J. A. Heddle. The in vivo micronucleus assay in mammalian bone marrow and peripheral blood. A report of the U S. Environmental Protection Agency Gene-Tox Program. Mutation Res 239 (1990), 29-80.
27. McMillan, T. J., J. H. Peacock: Molecular determinants of radiosensitivity in mammalian cells. Int. J. Radiat Biol. 65 (1984), 49-55
28. Milas, L., N. Hunter, B. O. Reid, D. Thames: Protective effects of S-2-(3-aminopropylamino)ethylphosphorothioic acid against radiation damage of normal tissues and a fibrosarcoma in mice. Cancer Res. 42 (1982), 1838-1897.
29. Morales-Ramirez, P., T. Vallarino-Kelly, J. Mercader-Martinez, R. Rodriguez-Reyes: Induction of micronuclei by acute and chronic exposure in vivo to gamma rays in murine polychromatic erythrocytes. Mutation Res 341 (1994), 47-55.
30. Murray, D., S. C. Van Ankeren, L. Milas, R. E. Meyn: Radioprotective action of aminothiols in vitro and in vivo: comparison between effects on DNA damage and cell survival. Pharmacol. Ther. 39 (1988), 151-153.
31. Natarajan, A. T.: Mechanisms for induction of mutations and chromosome alterations. Environ. Hlth. Perspect 101, Suppl. 3 (1993), 225-229.
32. Non, D., J. H. Kim, B. Hilaris, F. C. Chu: Radiosensitizers and protectors. In. Radiation therapy of gynecological cancer. Alan R. Liss, Inc New York. 1987, p 319-329.
33. Pascoe, S., D. Gatehouse: The use of a single haematoxylin and eosin staining procedure to demonstrate micronuclei within rodent bone marrow. Mutation Res. 164 (1986), 237-243.
34. Path, H. M., S H. Mayer, R. L Straube, E. M. Jackson: Radiation dose reduction by cysteine. J. comp. Physiol. 42 (1953), 327-341.
35. Path, H M., E. B. Tyree, R. L. Straube, D. E Smith: Cysteine protection against X-irradiation. Science 110 (1949), 213-214.
36. Phillips, J. W., W F. Morgan: DNA double-strand breaks in mutagenesis. Environ molec. Mutagen. 22 (1993), 214-217.
37. Ribeiro, L. R., C. S. Takahashi, B. Erdtman, S. V. Oliveira, C. T. Alvares da Costa, M. C. Gimmeler-Luz: Inter-laboratory calibration program for the mouse micronucleus test. Rev. bras. Genet. 16 (1993), 631-638.
38. Rojas, A., J. Denekamp: Modifiers of radiosensitivity. Experientia 45 (1989), 41-52.
39. Romantsev, E. F., I V. Filippovich, Z I. Zhulanova, V. D. Blokhina, Z. A. Trebenok, E. E. Kolesnikov, T. N. Sheremetyevskaya, A V. Nikolsky, O. G. Zymaleva: Effect of modifying factors on radiosensitive biochemical reactions. In: Biochemical indicators of radiation injury in man. International Atomic Energy Authority, Vienna 1971, 105-112.
40. Saran, M., W. Bors: Radical reactions in vivo - an overview. Radiat environ. Biophys. 29 (1990), 249-262.
41. Savage, J. R. K.: Update on target theory as applied to chromosomal aberrations. Environ. molec. Mittagen. 22 (1993), 198-207.
42. Schrmd, W.: The micronucleus test. Mutation Res. 31 (1975), 9-15.
43. Shaw, L M., D Glover, A. Turrisi, D. Q. Brown, H. S. Bonner, A. L. Norfleet, C. Weiler, J H. Glick, M M. Kligerman: Pharmacokinetics of WR-2721. Pharmacol Ther. 39 (1988), 195-201.
44. Shinoda, M., S. Ohta (nee Shimizu), T. Hino, M. Chiba (nee Goto), S. Akaboshi: Pharmacological studies on chemical protectors against radiation. VIII. Radioprotective activities of cysteamine and its related compounds. Yakugaku Zashi 93 (1973), 25-29.
45. Shinoda, M., S. Ohta (nee Shimizu), Y. Takagi, S Akaboshi: Studies of chemical protectors against radiation. XIV. Radiation protective activites of sulfur containing compounds against X-irradiation Yakugaku Zashi 94 (1974), 1419-1424.
46. Shinoda, M., S. Shimizu, T. Hino, B. Tamaoki, S. Akaboshi: Pharmacological studies on chemical protectors against radiation. VII. Radiation protective activities of AET and its related compounds against X-irradiation. Yakugaku Zashi 92 (1972), 442-448.
47. Sorenson, J. R. J.: Essential metalloelement metabolism and radiation protection and recovery. Radiat. Res. 132 (1992), 19-29
48. Takagi, Y., S. Shimizu, M. Shikita, M. Shinoda, S. Akaboshi: Radiation protection of mice by mixtures of β-mercaptoethylquanidine (MEG) and cysteamine (MEA). Chem. Pharm. Bull. 19 (1971), 2000-2002.
49. Weiss, J. F., K. S. Kumar, T. L. Walden, R Neta, M. R Landauer, E. P. Clark: Advances in radioprotection through the use of combined agent regimens. Int. J. Radiat. Biol. 57 (1990), 709-722
50. 50(30) doses. Radiat. Res. 44 (1970), 621-628.
51. Zetterberg, G., J. Grawe: Flow cytometric analysis of micronucleus induction in mouse erythrocytes by γ-irradiation at very low dose-rate. Int. J. Radiat. Biol. 64 (1983), 555-564.